Zoan Biomed Partnership with the European Maritime Fisheries Fund

In 2019 we launched our partnership with the European Maritime and Fisheries Fund of the European Union, CORAL4HEALTH. A 2-year engagement that initiated with high expectations and acknowledgment of the considerable innovation challenges that lay ahead.

The overall aim of the CORAL4HEALTH project was to commercialise the next generation graft bone substitutes, drawn from a sustainable, ethical and high-quality source of marine coral. The major challenge was the utilization of this important, heavily protected marine resource and demonstrating the ability to supply at scale – without having any environmental impact.

The project has made significant progress in bringing Zoan to industrial scale, building on past work, as well as putting in place the regulatory and quality approvals needed to launch its product onto the market.

The engagement has been an outstanding success and highlights the important role of funding from the EU, in bringing early-stage innovative companies to the market. 

The European Maritime and Fisheries Fund looks to support coastal communities in diversifying their economies and support sustainable maritime related businesses and this is a great example of their goals being met. 

We thank the EU for their support and look to the future with confidence and further opportunities together.

Zoan Biomed Partnership with the European Maritime Fisheries Fund

Latest News

Our Sustainability Model

As a Med Tech company that aims to improve people’s health, we recognise the need to preserve a healthy environment. The link between human and environmental health is well established: the WHO states that one in four premature deaths is related to environmental issues caused by humans and the World Bank acknowledges that sustainable management…

Novel Collaboration between Zoan Biomed and University of Galway to Assess Laboratory Bone Formation

Zoan Biomed and the University of Galway to develop high throughput rapid assessment methods for biocompatibility and osteogenic potential of orthopaedic scaffold; reducing time to clinical data and developing a path to remove the need for animal testing.

Zoan Biomed featured in Bonezone

Zoan Biomed were delighted to be featured in the August edition of the leading orthopaedic industry magazine, Bonezone, a popular US publication covering the most prominent breakthroughs in Orthopaedics.

Northwell Health USA and Portershed Galway Visit Zoan

We were delighted to have the opportunity to host, Mary Rodgers (CEO, PorterShed Galway) ,
Kevin Beiner (Senior Vice President and Regional Executive Director, Northwell Health) Elaine
Brennan (Executive Director & Chief Commercialization Officer at Northwell Health) Jennifer
Scanlon (AVP Strategic Partnerships at Northwell Health) to our facility last week.

Contact Us

To find out more about Zoan BioMed get in touch